The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
LettersFull Access

Antecollis, Lingual Dystonia, and Mutism Secondary to Risperidone

To the Editor: Tardive dystonia, although described nearly 30 years back, has received little attention among neuroleptic-induced movement disorders. It has been defined as a persistent dystonia arising during or within 3 months of neuroleptic discontinuation, in absence of family history of primary idiopathic dystonia or other secondary causes like Wilson’s disease, Huntington’s disease, Parkinson’s disease, stroke, etc.1 Tardive dystonia most often involves cervical and cranial regions but may also affect extremities and trunk when fully developed.2 In a majority the neck is involved especially as torticollis and less commonly as retrocollis and laterocollis.3 Antecollis, which is defined as sustained flexion of neck, is an unusual clinical presentation and has rarely been described.4 Oro-mandibular movements are common and present as jaw opening, closing or deviation while lingual involvement manifests as tongue protrusion or dyskinesia.5 We describe a case of a girl with tardive dystonia secondary to Risperidone presenting with antecollis, tongue dystonia and mutism.

Case Report

Ms. B. a 12-year-old female was initially brought to psychiatric unit of our hospital 3 years back for persistent learning difficulties. Her parents reported significant delay in motor development and language acquisition. Her vocabulary consisted of few words and simple sentences. She ate and took bath on her own but required mother’s help for dressing. Comprehensive assessment revealed severe mental retardation (IQ: 27). The parents were counseled about her prognosis and remedial education was suggested. Subsequent consultation took place 1 1/2 years back when she developed behavioral problems in the form of irritability, aggression and impairment of sleep. She was admitted and prescribed risperidone 2 mg/day and trihexyphenydyl 4 mg/day, with good initial improvement. She was discharged in 2 weeks after which she remained asymptomatic for 5 months. About a year back, Ms. B. experienced gradually increasing forward bending of neck which interfered with chewing and reduced her oral intake significantly. Her speech production also suffered and she became silent. Antecollis was relieved only during sleep. There was no history of high grade fever, vomiting, seizures or head and neck injury before the presenting illness. There was no history of movement disorder in the family.

During the assessment she followed simple commands but remained mute. Her neck was flexed and chin was pressed hard against the sternum. Rigidity was present only in the neck while trunk and limbs were free from rigidity, tremors, bradykinesia or other abnormal movements. Deep tendon and superficial plantar reflexes were normal. Oral examination revealed depressed tongue pressed against the base of the mouth and lower incisors; it bore indentation marks anteriorly. She was able to protrude her tongue with much difficulty. No oro-mandibular-lingual dyskinetic movements were observed. Investigations including- creatinine phosphokinase (CPK), Magnetic resonance imaging (MRI) of head and neck, electroencephalography (EEG) and cerebrospinal fluid examination (CSF) were normal. X-ray of cervical spine showed severe antecollis but was otherwise normal. Slit lamp examination of eyes did not show Keyser-Fleisher rings. Based on the above findings her condition was diagnosed as segmental cranio-cervical tardive dystonia, manifesting as severe antecollis and tongue dystonia.

After detailed discussion with her parents about diagnosis, available treatment options and on obtaining their informed consent, risperidone was slowly tapered down while clonazepam (2 mg/day) and vitamin E (400 mg/day) were added to trihexyphenydyl. Treatment with botulinum toxin was suggested but declined by the parents. Because of her chewing difficulties she was initially given semisolid diet, but as her dystonia and oral intake improved over the next 2 months solids were added. She was closely observed for emergence of behavioral problems; however, she remained well without risperidone. She was discharged after 2 months and assessed periodically. After nearly 6 months of commencement of treatment, parents reported significant improvement as she was able hold her head erect for longer periods; her tongue movements and speech output also improved substantially. Her oral intake and weight returned to her usual levels. At the time of writing this report Ms. B has been well for more than 10 months on the same treatment without any recurrence of dystonia or behavioral problems.

Discussion

Tardive dystonia begins focally in the cranio-cervical region and progresses to segmental distribution; generalized involvement being quite rare.2,6 This case illustrates at least three unusual presentations of tardive dystonia. First is antecollis, which is rarely reported and to our knowledge there is only one report where three cases of severe antecollis are described in detail.4 Antecollis is often reported in primary neurological illnesses like multiple system atrophy (MSA), Parkinson’s disease and progressive supranuclear palsy79 but rarely as tardive phenomenon. The static nature of muscle involvement in antecollis, as opposed to hyperkinetic presentations in majority of cases of tardive dystonia, could be the reasons for its low detection.4

In tardive dystonia, tongue involvement typically manifests as protrusion or dyskinesias.5 Sustained tongue depression with mutism as manifestation of tongue dystonia has not been described till date. Mutism, in fact led us to consider catatonia as initial diagnosis; a strong possibility, seeing that the patient had mutism and rigidity. However, rigidity was not generalized and the patient lacked negativism; hence catatonia was ruled out.

Consultant Psychiatrist, Department of Psychiatry, Kailash Hospital, Greater Noida, India

Specialist, Department of Psychiatry, Hindu Rao Hospital, New Delhi, India

References

1 Burke RE, Fahn S, Jankovic J, et al.: Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 1982; 32:1335–1346Crossref, MedlineGoogle Scholar

2 van Harten PN, Kahn RS: Tardive dystonia. Schizophr Bull 1999; 25:741–748Crossref, MedlineGoogle Scholar

3 Owens DG: Dystonia—a potential psychiatric pitfall. Br J Psychiatry 1990; 156:620–634Crossref, MedlineGoogle Scholar

4 Maeda K, Ohsaki T, Kuki K, et al.: Severe antecollis during antipsychotics treatment: a report of three cases. Prog Neuropsychopharmacol Biol Psychiatry 1998; 22:749–759Crossref, MedlineGoogle Scholar

5 Tan EK, Jankovic J: Tardive and idiopathic oromandibular dystonia: a clinical comparison. J Neurol Neurosurg Psychiatry 2000; 68:186–190Crossref, MedlineGoogle Scholar

6 Kiriakakis V, Bhatia KP, Quinn NP, et al.: The natural history of tardive dystonia. A long-term follow-up study of 107 cases. Brain 1998; 121:2053–2066Crossref, MedlineGoogle Scholar

7 Rivest J, Quinn N, Marsden CD: Dystonia in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy. Neurology 1990; 40:1571–1578Crossref, MedlineGoogle Scholar

8 Uzawa A, Mori M, Kojima S, et al.: Dopamine agonist-induced antecollis in Parkinson’s disease. Mov Disord 2009; 24:2408–2411MedlineGoogle Scholar

9 Boesch SM, Wenning GK, Ransmayr G, et al.: Dystonia in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002; 72:300–303Crossref, MedlineGoogle Scholar